Allergan-Inamed merger changes cosmetic playing field
We will be looking for ways to maximize all three product portfolios (breast aesthetics, dermal fillers and obesity intervention) and will be allocating the necessary resources and focus to ensure optimal growth," Mr. [Steven Pal] says. "For example, Allergan intends to retain all of Iname...
Gespeichert in:
Veröffentlicht in: | Dermatology Times 2006-05, Vol.27 (5), p.1 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | We will be looking for ways to maximize all three product portfolios (breast aesthetics, dermal fillers and obesity intervention) and will be allocating the necessary resources and focus to ensure optimal growth," Mr. [Steven Pal] says. "For example, Allergan intends to retain all of Inamed's field sales forces, thereby doubling its existing Botox Cosmetic sales force, and to make incremental investment in its obesity/Lap-Band System sales force. |
---|---|
ISSN: | 0196-6197 2150-6523 |